Supreme Court Allows Cross-Examination on Brand Use Despite Written Statement Not Being on Record || Supreme Court: Enquiry Needed Before Dismissal for Suppressing Criminal Antecedents || Supreme Court: Trading While Holding Confidential Information Indicates Insider Trading || Supreme Court Explains Four-Step Test to Quash Criminal Cases Using Defence Material || Supreme Court Acquits Man in Minor Rape Case, Flags HC's Medical Evidence Lapse || Bombay HC: Minor’s Inability to Describe Sexual Act No Ground to Reject Her Testimony || Delhi HC: Wife’s Interim Maintenance Cannot be Based Solely on Husband’s Income || Calcutta HC: SLSA Cannot Adopt ‘Big Brother’ Approach Over Adult Victims’ Compensation || Allahabad HC: Further Investigation Permissible Even After Final Report is Accepted || Allahabad HC: Court-Directed Award Cannot be Challenged for Not Computing Market Value

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :